Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The visual pathway as a model to understand brain damage in multiple sclerosis.
Involvement of JAK/STAT signaling in the effect of cornel iridoid glycoside on experimental autoimmune encephalomyelitis amelioration in rats.
Defining the new end point for multiple sclerosis treatment.
An anomalous case of acute coronary syndrome: the unexpected autoimmune duo.
The immunogenetics of multiple sclerosis: A comprehensive review.
Enhanced Neuroprotective Effects of Combination Therapy with Bone Marrow-Derived Mesenchymal Stem Cells and Ginkgo biloba Extract (EGb761) in a Rat Model of Experimental Autoimmune Encephalomyelitis.
Efficacy and safety of FTY720 in patients with relapsing multiple sclerosis
Heat sensitive persons with multiple sclerosis are more tolerant to resistance exercise than to endurance exercise.
S1P1 Receptor Upregulation and Amelioration of Experimental Autoimmune Encephalomyelitis by an S1P1 Antagonist.
Downbeat nystagmus associated with damage to the medial longitudinal fasciculus of the pons: A vestibular balance control mechanism via the lower brainstem paramedian tract neurons.
A novel method for calculating prevalence of multiple sclerosis in Australia.
MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis.
Assessing spinal cord function in multiple sclerosis with functional neuroimaging: insights and limitations.
Beneficial effects of Rituximab in patients with anti-MAG (myelin-associated glycoprotein) neuropathy: case reports.
Dimethyl fumarate: a review of its use in patients with relapsing-remitting multiple sclerosis.
Core outcome measures for exercise studies in people with multiple sclerosis: recommendations from a multidisciplinary consensus meeting.
The ICF as a framework to collect and interpret data on the extent and variety of disability in neurological conditions.
Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells.
Fingolimod in the treatment of relapsing-remitting multiple sclerosis: long-term experience and an update on the clinical evidence.
Medical and Nonstroke Neurologic Causes of Acute, Continuous Vestibular Symptoms.
Long-term treatment of relapsing-remitting multiple sclerosis with interferon β: how strongly should we encourage patients to adhere to the 'old' therapies?
Employment as a health promotion intervention for persons with multiple sclerosis.
A new therapeutic target for the treatment of multiple sclerosis.
Myelin-derived lipids modulate macrophage activity by liver x receptor activation.
Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome.

Pages